The prognostic role of inflammation-scores on overall survival in lung cancer patients.

Birgitte Sandfeld-PaulsenPeter MeldgaardBoe S SorensenAkmal SafwatNinna Aggerholm-Pedersen

Published in: Acta oncologica (Stockholm, Sweden) (2019)

In this cohort of lung cancer patients, we demonstrate that inflammation-scores are prognostic markers of inferior survival. Furthermore, we demonstrate that the optimized inflammation-scores CNG and ACBS lead to better patient-allocation independently of the clinicopathological characteristics and comorbidity.

Keyphrases

oxidative stress
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
patient reported